CBD Gummies for Breathing: What to Know Before Trying Them
CBD gummies for breathing concerns are increasingly popular, but evidence remains limited. Understanding the clinical data gap is essential before trying them. Patients should consult healthcare providers for proper evaluation.
CBD Gummies Sexuality: What the Evidence Shows for Libido, Relaxation, and Intimacy
CBD gummies for sexual health are increasingly popular for their potential effects on libido and relaxation. Current evidence for these gummies' impact on sexual function is limited and mostly anecdotal. Understanding the role of CBD gummies for sexual…
Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL – Nature
This study investigates ibrutinib resistance mechanisms in ABC-DLBCL, focusing on the role of miR-28. Understanding these pathways is crucial for advancing lymphoma treatment. The research highlights potential targets to overcome drug resistance.
Treating Cyclic Vomiting and Cannabinoid Hyperemesis: What the Evidence (and Experts) Currently Support
More research is needed to develop evidence-based, individualized abortive treatment plans, as well as to determine whether the abortive treatment for CVS requires a fundamentally different approach than for CHS.
Only Five Trials Found: Cannabinoids for Post-Surgery Pain Remain an Open Question
The focus on cannabinoids acute postoperative pain reveals only five trials with contradictory results. This scarcity of data prevents meta-analytic evaluations and clinical recommendations. More standardized research is essential to clarify their role…
CBD Chewing Gum: Promising Concept, Thin Evidence
CBD chewing gum drug delivery is a promising concept with limited clinical evidence. Research gaps remain in absorption mechanisms, dosing precision, and long-term safety. Current trials show no significant efficacy over placebo.
Medical Cannabis for Arthritis Pain: What the Evidence Really Shows
Despite promising preclinical and observational evidence, medical cannabis rheumatic pain treatment lacks high-quality clinical trials. This 2024 review highlights the gap between patient use and clinical evidence. Clinicians should engage patients…
Medical Cannabis in Older Adults: Promising Interest, Thin Evidence
Medical cannabis safety older adults is a critical concern due to limited evidence and unique risks in this population. Current studies mostly exclude adults over 60, leaving a gap in clinical guidance. Careful individualized decision-making is essential…
Older Adults and Medical Cannabis: Promising Interest, Scarce Evidence
Medical cannabis older adults safety is a critical concern given limited evidence. Most studies focus on younger populations, leaving gaps in geriatric data. Risks include cognitive and cardiovascular effects unique to older adults.